S. Caglioti

发表

A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors

S. Glynn, S. Kleinman, M. Busch, 2005, Transfusion.

NAT of the United States and Canadian blood supply

S. Stramer, D. Strong, S. Caglioti, 2000, Transfusion.

Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003

M. Drebot, J. Saldanha, V. Shyamala, 2005, Transfusion.

Clinical specificity and sensitivity of a blood screening assay for detection of HIV‐1 and HCV RNA

L. Mimms, C. Giachetti, S. Stramer, 2002, Transfusion.

Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms

S. Kleinman, M. Busch, S. Stramer, 2006, Transfusion.

Triggers for switching from minipool testing by nucleic acid technology to individual‐donation nucleic acid testing for West Nile virus: Analysis of 2003 data to inform 2004 decision making

P. Tomasulo, B. Custer, M. Busch, 2004, Transfusion.

Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates

Michael P. Busch, Sally Caglioti, Thomas R. O'Brien, 2007, Journal of Clinical Microbiology.

Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.

Sally Caglioti, Michael P Busch, Roger Y Dodd, 2004, The New England journal of medicine.

Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing.

Peter Tomasulo, Hany Kamel, Sally Caglioti, 2005, The New England journal of medicine.

Clinical significance of nondiscriminated reactive results with the Chiron Procleix HIV‐1 and HCV assay

M. Busch, L. Tobler, Robert C. Williams, 2004, Transfusion.

Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay

D. Kessler, G. Wormser, P. Krause, 2014, Transfusion.

Phylogenetic analysis of WNV in North American blood donors during the 2003-2004 epidemic seasons.

E. Delwart, J. Saldanha, B. Herring, 2007, Virology.

Chagas disease and the US blood supply

S. Montgomery, C. Bern, L. Katz, 2008, Current opinion in infectious diseases.

West Nile virus testing experience in 2007: evaluation of different criteria for triggering individual‐donation nucleic acid testing

P. Tomasulo, M. Busch, S. Kleinman, 2009, Transfusion.

Virus and antibody dynamics in acute west nile virus infection.

R. Lanciotti, H. Kamel, S. Kleinman, 2008, The Journal of infectious diseases.

Genetic Variability of West Nile Virus in US Blood Donors, 2002–2005

S. Rossmann, S. Stramer, M. Ríos, 2008, Emerging infectious diseases.

Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi

H. Kamel, P. Tomasulo, R. Cusick, 2012, Transfusion.

In vitro evaluation of the protective role of human antibodies to West Nile virus (WNV) produced during natural WNV infection.

I. Hewlett, J. Epstein, A. Dayton, 2008, The Journal of infectious diseases.

In vitro evaluation of the protective role of human antibodies to West Nile virus (WNV) produced during natural WNV infection.

S. Stramer, S. Caglioti, O. Wood, 2008, The Journal of infectious diseases.